Neurotrophic effects of fibroblast growth factor-like autoantibodies in serum from three patients with breast cancer

Brain Research

Volumn 1251, Issue , 2009, Pages 276-286

  Zimering, Mark B ^a,b   Alder, Janet ^b   Thakker Varia, Smita ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Autoantibodies; Breast cancer; Fibroblast growth factor; Neurotrophic

Indexed keywords

AUTOANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL LOSS; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; CONTROLLED STUDY; HIPPOCAMPUS; ION CURRENT; LUPUS VULGARIS; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN STABILITY; RAT;

AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; BREAST NEOPLASMS; CARCINOMA; CELL DEATH; CELLS, CULTURED; CYTOPROTECTION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEUROGENESIS; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; TIME FACTORS;

RATTUS;

EID: 58149392975     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.11.035     Document Type: Article

References (44)

1. Anderson K.J., Dam D., Lee S., and Cotman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332 (1988) 360-361
2. Aoyagi A., Nishikawa K., Saito H., and Abe K. Characterization of basic fibroblast growth factor-mediated acceleration of axonal branching in cultured rat hippocampal neurons. Brain Res. 661 (1994) 117-126
3. Bethel A., Kirsch J.R., Koehler R.C., and Finklestein S.P. Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats. Stroke 28 (1997) 609-615
4. Blanchard B.J., Konopka G., Russell M., and Ingram V.M. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease. Brain Res. 776 1-2 (1997) 40-50
5. Boxer A.L., Moreno H., Rudy B., and Ziff E.B. FGF-2 potentiates Ca-dependent inactivation of NMDA receptor currents in hippocampal neurons. J. Neurophysiol. 82 6 (1999) 3367-3377
6. Briozzo P., Badet J., Capony F., Pieri I., Montcourrier P., Barritault D., and Rochefort H. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp. Cell Res. 194 2 (1991) 252-259
7. Caccia P., Nitti G., Cletini O., Pucci P., Ruoppolo M., Bertolero F., Valsasina B., Roletto F., Cristiani C., Cauet G., et al. Stabilization of recombinant human basic fibroblast growth factor by chemical modifications of cysteine residues. Eur. J. Biochem. 204 2 (1992) 649-655
8. Chan E.K., and Tan E.M. Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J. Exp. Med. 166 6 (1987) 1627-1640
9. Cheng B., McMahon D.G., and Mattson M.P. Modulation of calcium current, intracellular calcium levels, and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Res. 607 1-2 (1993) 275-282
10. Chi C.L., Martinez S., Wurst W., and Martin G.R. The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum. Development 130 12 (2003) 2633-2644
11. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
12. David C., Solimena M., and De Camilli P. Autoimmunity in stiff-man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161. FEBS Lett. 351 1 (1994) 73-79
13. Dirix L.Y., Vermeulen P.B., Pawinski A., Prové A., Benoy I., De Pooter C., Martin M., and Van Oosterom A.T. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br. J. Cancer. 76 2 (1997) 238-243
14. Distasi C., et al. Neuronal survival and calcium influx induced by bFGF in chick ciliary ganglion neurons. Eur. J. Neurosci. 10 7 (1998) 2276-2286
15. Elbaz A., Peterson B.J., Yang P., Van Gerpen J.A., Bower J.H., Maraganore D.M., McDonnell S.K., Ahlskog J.E., and Rocca W.A. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 13 2 (2002) 157-164
16. Esch F., Baird A., Ling N., Ueno N., Hill F., Denoroy L., Klepper R., Gospodarowicz D., Bohlen P., and Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc. Natl. Acad. Sci. U. S. A. 19 (1985) 6507-6511
17. Feige J.J., and Baird A. Basic fibroblast growth factor is a substrate for protein phosphorylation and is phosphorylated by capillary endothelial cells in culture. Proc. Natl. Acad. Sci. U. S. A. 86 9 (1989) 3174-3178
18. Fillit H., and Mulvihill M. Association of autoimmunity to vascular heparan sulfate proteoglycan and vascular disease in the aged. Gerontology 39 (1993) 177-182
19. Fillit H.M., Kemeny E., Luine V., Weksler M.E., and Zabriskie J.G. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J. Gerontol. 42 2 (1987) 180-184
20. Fuxe K., Chadi G., Tinner B., Agnati L.F., Pettersson R., and David G. On the regional distribution of heparan sulfate proteoglycan immunoreactivity in the rat brain. Brain Res. 636 1 (1994) 131-138
21. Givol D., and Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6 15 (1992) 3362-3369
22. Gospodarowicz D., Cheng J., Lui G.M., Baird A., and Bohlen P. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 6963-6967
23. Gospodarowicz D., Ferrara N., Schweigerer L., and Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8 (1987) 95-114
24. Hanafusa H., Torii S., Yasuaga T., and Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4 11 (2002) 850-858
25. Hill D.J., Tevaarwerk G.J., Arany E., Kilkenny D., Gregory M., Langford K.S., and Miell J. Fibroblast growth factor-2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1. J. Clin. Endocrinol. Metab. 80 6 (1995) 1822-1831
26. Jerne N.K. Towards a network theory of the immune system. Ann. Immunol. (Paris) 125C 1-2 (1974) 373-389
27. Joannides A.J., Fiore-Hériché C., Battersby A.A., Athauda-Arachchi P., Bouhon I.A., Williams L., Westmore K., Kemp P.J., Compston A., Allen N.D., and Chandran S. A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 25 3 (2007) 731-737
28. Kalir H.H., and Mytilineou C. Ascorbic-acid in mesencephalic cultures-effects of dopaminergic neuron development. J. Neurochem. 57 (1991) 458-464
29. Kwabi-Addo B., Wang J., Erdem H., Vaid A., Castro P., Ayala G., and Ittmann M. The expression of sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res. 64 14 (2004) 4728-4735
30. Levine E.S., Dreyfus C.F., Black I.B., and Plummer M.R. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc. Natl. Acad. Sci. U. S. A. 92 17 (1995) 8074-8077
31. Levine E.S., Crozier R.A., Black I.B., and Plummer M.R. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-d-aspartic acid receptor activity. Proc. Natl. Acad. Sci. U. S. A. 95 17 (1998) 10235-10239
32. Matsuda S., Saito H., and Nishiyama N. Effect of basic fibroblast growth factor on neurons cultured from various regions of postnatal rat brain. Brain Res. 520 (1990) 310-316
33. Peterson D.A., Lucidi-Phillipi C.A., Murphy D.P., Ray J., and Gage F.H. Fibroblast growth factor-2 protects entorhinal layer II neurons after perforant path axotomy. Brain Res. 591 (1992) 271-276
34. Renaudineau Y., Revelen R., Bordron A., Mottier D., Youinou P., and Le Corre R. Two populations of endothelial cell antibodies cross-react with heparin. Lupus 7 2 (1998) 86-94
35. Satoh M., Ajmani A.K., Ogasawara T., Langdon J.J., Hirakata M., Wang J., and Reeves W.H. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera. J. Clin. Invest. 94 5 (1994) 1981-1989
36. Storm E.E., Rubenstein J.L., and Martin G.R. Dosage of Fgf8 determines whether cell survival is positively or negatively regulated in the developing forebrain. Proc. Natl. Acad. Sci. U. S. A. 100 4 (2003) 1757-1762
37. Takayama H., Ray J., Raymon H.K., Baird A., Hogg J., Fishcer L.J., and Gage F.H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1 (1995) 53-58
38. Thakker-Varia S., Alder J., Crozier R.A., Plummer M.R., and Black I.B. Rab3A is required for brain-derived neurotrophic factor-induced synaptic plasticity: transcriptional analysis at the population and single-cell levels. J. Neurosci. 21 17 (2001) 6782-6790
39. Tornqvist, N., Björklund, L., Almqvist, P., Wahlberg, L., Strömberg, I., 2000. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Exp. Neurol. 164 (1), 130-138.
40. Unger E.F., Goncalves L., Epstein S.E., Chew E.Y., Trapnell C.B., Cannon III R.O., and Ouyyumi A.A. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am. J. Cardiol. 85 12 (2000) 1414-1419
41. Vlodavsky I., Miao H.Q., Medalion B., Danagher P., and Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 15 2 (1996) 177-186
42. Walicke P., Cowan W.M., Ueno N., Baird A., and Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 3012-3016
43. Zimering M.B., and Thakker-Varia S. Increased fibroblast growth factor-like autoantibodies in serum from a subset of patients with cancer-associated hypercalcemia. Life Sci. 71 (2002) 2939-2959
44. Zimering M.B., Riley D.J., Thakker-Varia S., Walke A.M., Lakshminaryan V., Shah R., Brandi M.L., Ezzat S., Katsumata N., Friesen H.G., Marx S.J., and Eng J. Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type 1 and prolactinoma. J. Clin. Endocrinol. Metab. 79 (1994) 1546-1552